HDAC9 and autosomal dominant polycystic kidney disease: Multiple studies in ADPKD pre-clinical models showed reduced cyst formation, cyst growth, improved renal function, and decreased cell proliferation following HDAC inhibition (Liu & Zhuang 2015).